| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.4 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.14 | 0.4 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |